Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in idiopathic hypersomnia long-term extension
NCT05458128Phase 3Completed
- Sponsor
- Harmony Biosciences
- Start
- Aug 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitolisant in idiopathic hypersomnia (IH), sponsored by Harmony Biosciences. Started Aug 2022; status: completed.
02
Drugs
pitolisant
03
Conditions
idiopathic hypersomnia (IH)
Beyond the preview
Go deeper on NCT05458128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458128.